Magazine Article | March 1, 2021

Small Pharma-Service Entrepreneurs Make A Big Impact

Source: Life Science Leader

By Brian Scanlan

During the past decade, the consolidation activity in the outsourced pharma services world has left a giant chasm between the global giants and the small entrepreneurial service providers. Transaction activity has been strong, with over 400 deals in the past five years alone. In the U.S., the large global CDMOs have acquired a majority of the remaining independent midsize players, leaving many of my colleagues challenged to name more than a handful of truly independent midsize pharma services firms remaining in the U.S. today.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: